Lakefront Biotherapeutics (LKFT) Depreciation and Depletion (2016 - 2018)

Lakefront Biotherapeutics (LKFT) has 3 years of Depreciation and Depletion data on file, last reported at $1.1 million in Q3 2018.

• Depreciation and Depletion for Q3 2018 came in at $1.1 million, up 5.0% year-over-year; the trailing twelve-month figure through Sep 2018 was $4.4 million (up 11.28% YoY), and the FY2017 annual result was $4.3 million, up 19.26% from the prior year.
• Depreciation and Depletion was little changed at $1.1 million in Q3 2018 per LKFT's latest filing, from $1.1 million in the prior quarter.
• Over five years, Depreciation and Depletion peaked at $1.1 million in Q3 2018 and troughed at $832774.2 in Q1 2016.
• A 3-year average of $1.0 million and a median of $1.0 million in 2017 frame the typical range for Depreciation and Depletion.
• On a YoY basis, Depreciation and Depletion climbed as much as 13.55% in 2018 and fell as far as 5.0% in 2018.
• A 3-year view of Depreciation and Depletion shows it stood at $925367.6 in 2016, then increased by 10.7% to $1.0 million in 2017, then advanced by 10.93% to $1.1 million in 2018.
• Business Quant data shows LKFT's Depreciation and Depletion at $1.1 million in Q3 2018, $1.1 million in Q2 2018, and $1.0 million in Q4 2017.